Treatment Strategies and Outcomes in Patients with Infected Aortic Endografts
Endovascular abdominal (EVAR) and thoracic (TEVAR) endografts allow aneurysm repair in high-risk patients, but infectious complications may be devastating. We reviewed treatment and outcomes in patients with infected aortic endografts.
Comparison of Diagnostic Criteria for Acute Kidney Injury in Cardiac Surger
The objective of this study was to evaluate the incidence and risk factors for the development of Acute Kidney Injury (AKI) following cardiac surgery according to the RIFLE, AKIN and KDIGO criteria, and compare the prognostic power of these criteria.
Bloodstream Infections Occurring in Patients With Percutaneously Implanted Bioprosthetic Pulmonary Valve: A Single-center Experience
SYSTEMIC INFECTIONS IN MELODY VALVE IMPLANTED PATIENTS WITH AND WITHOUT IDENTIFIED VALVE INVOLVEMENT HAVE BEEN REPORTED, YET THE INCIDENCE IS UNKNOWN, AND RISK FACTORS REMAIN UNIDENTIFIED.
The Mechanisms of Cell Therapy for Clinical Investigations: An Urgent Need for Large-Animal Models
Evidence from experiments performed in animal models and from early-stage clinical trials demonstrate that the contractile performance of hearts with severe ischemic injury can be improved by transplanting a variety of cell types into the injured heart.
A Strong Regenerative Ability of Cardiac Stem Cells Derived from Neonatal Hearts
We hypothesized that isolated neonatal-derived cardiac stem cells (CSCs) may have a higher regenerative ability than adult-derived CSCs and might address the structural deficiencies of congenital heart disease.
Shovel-Ready’ Applications of Stem Cell Advances for Pediatric Heart Disease
This review will focus on two advances in basic science that are now translating into clinical trials.
Potential for Stem Cell Use in Congenital Heart Disease
This article reports on the evolving field of stem cell therapy and its impact on the management of cardiac pathology, in particular congenital heartdisease.
Characterization and functionality of cardiac progenitor cells in congenital heart patients
Human cardiac progenitor cells (hCPCs) may promote myocardial regeneration in adult ischemic myocardium. The regenerative capacity of hCPCs in young patients with nonischemic congenital heart defects for potential use in congenital heart defect repair warrants exploration.
Management of Patients with Hematological Malignancies Undergoing Coronary Artery Bypass Grafting
We describe three cases with hematological malignancies namely chronic myelogenous leukemia, acute promyelocytic leukemia and chronic lymphocytic leukemia presenting for coronary artery bypass grafting (CABG).
Monitoring Incomplete Heparin Reversal and Heparin Rebound After Cardiac Surgery
To assess the incidence of incomplete heparin reversal and heparin rebound after cardiac surgery with cardiopulmonary bypass (CPB) and the ability of the activated coagulation time (ACT) and thromboelastography (TEG) to detect these phenomena.
Results with an Anticoagulation Protocol in 99 SynCardia Total Artificial Heart Recipients
For 15 years, we employed a consistent anticoagulation protocol in 99 consecutive SynCardia Systems total artificial heart (TAH) recipients.
Mini-Extracorporeal Circulation Minimizes Coagulation Abnormalities and Ameliorates Pulmonary Outcome in Coronary Artery Bypass Grafting Surgery
Hemostasis is impaired during CABG and coagulation abnormalities often result in clinically relevant organ dysfunctions, eventually increasing morbidity and mortality rates.